Press release
Global Immunoglobulin G Antibody Therapeutics Market to Witness Unprecedented Growth In Coming Years 2020-2024 | Roche, Abbvie, J & J, Novartis, Merck, Takeda, Amgen, Biogen, AstraZeneca
Immunoglobulin G Antibody Therapeutics
Overview of Global Immunoglobulin G Antibody Therapeutics Market:
Immunoglobulin G (IgG) is a type of antibody. Representing approximately 75% of serum antibodies in humans, IgG is the most common type of antibody found in blood circulation. IgG molecules are created and released by plasma B cells. Each IgG has two antigen binding sites.
The report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the global Immunoglobulin G Antibody Therapeutics market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/270262 .
Growth in the historic period resulted from economic growth in emerging markets, the rise in awareness of the benefits and developed nations towards Immunoglobulin G Antibody Therapeutics costs and an increase in the number of Antibodies are major components of humoral immunity.
Product Type Segmentation:
The Immunoglobulin G Antibody Therapeutics market have different product type such as IgG1 and IgG4. Immunoglobulin G Antibody Therapeutics market product type the main type of antibody found in blood and extracellular fluid, allowing it to control infection of body tissues. By binding many kinds of pathogens such as viruses, bacteria, and fungi, IgG protects the body from infection.
Industry Segmentation:
Increasing instances across various sectors such as Autoimmune and Tumor are raising the need of healthcare institutes, thereby raising the demand for Immunoglobulin G Antibody Therapeutics market. This help in the profitable growth of the Global Immunoglobulin G Antibody Therapeutics market in upcoming year.
Segmentation by Regions:
The Immunoglobulin G Antibody Therapeutics market in North America has generated following class switching and maturation of the antibody response, thus they participate predominantly in the secondary immune response to help patients in the world. It was followed by Western Europe, China, Japan, Southeast Asia, India and Central & South America regions. Asia Pacific is expected to record higher growth rate in Immunoglobulin G Antibody Therapeutics Market during the forecast year.
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Immunoglobulin G Antibody Therapeutics Market Report 2020” @ https://www.businessindustryreports.com/buy-now/270262/single .
Top Leading Key Manufacturers are: Roche, Abbvie, J & J, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda, Amgen, Biogen, UCB, Eli Lilly and Company, AstraZeneca. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Top Industry News:
Roche’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints on 19 June, 2020 -- Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumours
Roche today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC) and whose tumours had PTEN loss. In this patient group, ipatasertib in combination with abiraterone and prednisone/prednisolone provided a statistically significant reduction in the risk of disease worsening or death, compared to current standard of care (abiraterone and prednisone/prednisolone) plus placebo. The other co-primary endpoint of rPFS in the overall study population (ITT) was not met. The safety profile for the combination of ipatasertib and abiraterone was consistent with previous analyses and known risks. The results of the IPATential150 study will be presented at an upcoming medical meeting.
While initial data are encouraging, overall survival benefit and additional secondary endpoints are not yet mature. The trial will continue until the next planned analysis and data will be shared with health authorities.
“Prostate cancer remains a leading cause of death in men worldwide and patients with metastatic castration-resistant prostate cancer can be difficult to treat,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “The early results of the IPATential150 study are encouraging in our ongoing mission to develop new treatment options for people with advanced prostate cancer.”
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/270262 .
Major Points in Table of Contents:
1 Immunoglobulin G Antibody Therapeutics Product Definition
2 Global Immunoglobulin G Antibody Therapeutics Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Immunoglobulin G Antibody Therapeutics Shipments
2.2 Global Manufacturer Immunoglobulin G Antibody Therapeutics Business Revenue
2.3 Global Immunoglobulin G Antibody Therapeutics Market Overview
2.4 COVID-19 Impact on Immunoglobulin G Antibody Therapeutics Industry
3 Manufacturer Immunoglobulin G Antibody Therapeutics Business Introduction
3.1 Roche Immunoglobulin G Antibody Therapeutics Business Introduction
3.1.1 Roche Immunoglobulin G Antibody Therapeutics Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Roche Immunoglobulin G Antibody Therapeutics Business Distribution by Region
3.1.3 Roche Interview Record
3.1.4 Roche Immunoglobulin G Antibody Therapeutics Business Profile
3.1.5 Roche Immunoglobulin G Antibody Therapeutics Product Specification
3.2 Abbvie Immunoglobulin G Antibody Therapeutics Business Introduction
3.2.1 Abbvie Immunoglobulin G Antibody Therapeutics Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Abbvie Immunoglobulin G Antibody Therapeutics Business Distribution by Region
3.2.3 Interview Record
3.2.4 Abbvie Immunoglobulin G Antibody Therapeutics Business Overview
3.2.5 Abbvie Immunoglobulin G Antibody Therapeutics Product Specification
3.3 J & J Immunoglobulin G Antibody Therapeutics Business Introduction
3.3.1 J & J Immunoglobulin G Antibody Therapeutics Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 J & J Immunoglobulin G Antibody Therapeutics Business Distribution by Region
3.3.3 Interview Record
3.3.4 J & J Immunoglobulin G Antibody Therapeutics Business Overview
3.3.5 J & J Immunoglobulin G Antibody Therapeutics Product Specification
3.4 Bristol-Myers Squibb Immunoglobulin G Antibody Therapeutics Business Introduction
3.5 Novartis Immunoglobulin G Antibody Therapeutics Business Introduction
3.6 Merck Immunoglobulin G Antibody Therapeutics Business Introduction
………………. Request free sample to get a complete Table of Content
About us
BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Immunoglobulin G Antibody Therapeutics Market to Witness Unprecedented Growth In Coming Years 2020-2024 | Roche, Abbvie, J & J, Novartis, Merck, Takeda, Amgen, Biogen, AstraZeneca here
News-ID: 2079451 • Views: …
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market:
This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market:
This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis:
The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…
More Releases for Immunoglobulin
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements …
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate?
There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, South…
Boosting Immunity: Innovations in Subcutaneous Immunoglobulin (SCIG)
The Business Research Company recently released a comprehensive report on the Global Subcutaneous Immunoglobulin (SCIG) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your…
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t …
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,…
Korea Intravenous Immunoglobulin Market Analysis to 2031
Intravenous Immunoglobulin Market Outlook 2031
The global intravenous immunoglobulin market was valued at US$ 11.2 Bn in 2021
It is estimated to grow at a CAGR of 7.3% from 2022 to 2031
The global intravenous immunoglobulin market is expected to reach value of US$ 20.5 Bn by the end of 2031
Get Sample Copy of the Report@
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930
Overview of Intravenous Immunoglobulin Market
Immunoglobulins are highly purified, sterile-specific medical therapy solutions containing gamma globulin G (IgG) in a concentration of 95% or more. These are manufactured from a highly…
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of…
